tradingkey.logo

GSK plc

GSK
View Detailed Chart

37.430USD

-0.070-0.19%
Close 04/25, 16:00ETQuotes delayed by 15 min
77.58BMarket Cap
23.79P/E TTM

GSK plc

37.430

-0.070-0.19%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.19%

5 Days

+4.17%

1 Month

-2.30%

6 Months

-0.24%

Year to Date

+10.67%

1 Year

-8.95%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 9 analysts
HOLD
Current Rating
39.172
Target Price
4.65%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
8
Average
Company name
Ratings
Analysts
GSK plc
GSK
9
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
32

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(3)
Neutral(2)
Buy(5)
Indicators
Sell(1)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.483
Neutral
RSI(14)
55.011
Neutral
STOCH(KDJ)(9,3,3)
95.381
Overbought
ATR(14)
1.310
Low Volatility
CCI(14)
118.809
Buy
Williams %R
8.571
Overbought
TRIX(12,20)
-0.308
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
36.708
Buy
MA10
35.811
Buy
MA20
36.431
Buy
MA50
37.564
Sell
MA100
35.964
Buy
MA200
37.693
Sell

News

More news coming soon, stay tuned...

Company

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Its specialty medicines prevent and treat diseases, from human immunodeficiency virus (HIV) to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases. Its portfolio also includes the lead molecule IDRX-42, highly selective tyrosine kinase inhibitor (TKI) that is designed to improve patients with gastrointestinal stromal tumors (GIST).
Company codeGSK
CompanyGSK plc
CEOMs. Deborah Waterhouse
Websitehttps://www.gsk.com/